Corbus Pharmaceuticals Holdings, Inc. Expense Breakdown
No Expense Breakdown for CRBP on this site yet.
- 2026-06-30: Personnel related $2.47M; Other unallocated $552.00K.
- 2025-06-30: Personnel related $2.28M; Other unallocated $435.00K.
Source checked: the stored Expense Breakdown page for CRBP.
Expenses by product
Research and development: each quarter (3 month)
| Quarter end | Personnel related | Other unallocated |
|---|---|---|
| 2026-06-30 | $2.47M | $552.00K |
| 2025-06-30 | $2.28M | $435.00K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |